4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-058061
SVP, Gen Counsel & Corp Sec sold 10,000 shares at $56.50 ($565,000)
- SVP, Gen Counsel & Corp Sec acquired 10,000 shares (option exercise)
- SVP, Gen Counsel & Corp Sec gave up 325 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2023-12-07 | Option exercise 10b5-1 | +10,000 | $21.41 | $214,100 | 31,035 | D |
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2023-12-07 | Sale 10b5-1 | −10,000 | $56.50 | $565,000 | 21,035 | D |
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2023-12-07 | Shares withheld for taxes 10b5-1 | −325 | $56.78 | $18,454 | 20,710 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2023-12-07 | Option exercise · Stock Option (right to buy) 10b5-1 | +10,000 | 195,000 | D | ||
| Open-market sales · 10,000 sh · avg $56.50 · $565,000 | |||||||
Loading xslF345X05/doc4.xml…